Solve Therapeutics, Inc.

CIK 1905252 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Solve Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 25, 2025D0001231919-25-000548
Dec 26, 2024D0001905252-24-000001
Jan 21, 2022D0001905252-22-000001